1. OPPORTUNITY ASSESSMENT
Providing comprehensive market understanding and insights to support investment and commercialization
DISEASE BACKGROUND MARKET OVERVIEW
• Etiology & pathophysiology • Epidemiology • Treatment algorithm • Market trends
• Patient segmentation • Demand analysis • Treatment guidelines • Future outlook
• Prescribing drivers/resistors • Growth drivers & resistors
• Current size
4C ANALYSIS
CUSTOMER ANALYSIS COMPETITOR ANALYSIS CONSUMER ANALYSIS CANDIDATE ANALYSIS
• KOL, treating physician and • Treatment algorithm • Market segmentation • TPP ideation and
payer interviews • Treatment guidelines • Market sizing (number of validation
• In-depth phone, face-to-face • Prescribing drivers and treatable patients; current • Stakeholder evaluations
interviews and online surveys resistors and future) • Gap analysis of TPP, pipeline
• Influence mapping • Current size • Current standard of care’s and existing products to
• Decision-making process • Market trends strengths and weaknesses unmet needs
• Requirements and unmet needs • Future outlook/growth drivers • Unmet needs
• Price point testing resistors
VALUATION INSIGHTS AND RECOMMENDATIONS
• Approach: patient and/or • Ouputs: • Key findings • High-value market targeting
demand-based forecast models - Volume, sales • Drivers and resistors • Optimized product proposition
• Inputs: - Scenarios and assumptions • Medical and commercial and positioning
- Best available data • Results Audit: implications • Strategic recommendations
- Prices - Triangulation
- Uptake curves - Statistical analyses
- Market shares - Quality control
INFORMING YOUR CRITICAL DECISIONS
Knowledge Building Internal or External Valuations
Ensuring you have the right information on new markets and Providing robust financial information for your go/no-go,
indications to support your pipeline and newly-launched products in-licensing, out-licensing and partnering decisions.
by leveraging our robust research and information sources.
Portfolio Management
Setting Strategic Direction Working closely with you, we bring clarity when assessing
Building your product concepts and testing product profiles, we help product(s) in the context of your overall portfolio, and fully evaluate
you to define and position your business against its future challenges. the options available, potential scenarios and resulting impacts.
Our consultants operate globally; our head offices are located in:
UK 119 Farringdon Road, London EC1R 3DA | +44 (0)20 7675 7000
US 52 Vanderbilt Avenue, 7th Floor, New York, NY 10017 | +1 (212) 686 7400 info@datamonitorconsulting.com
Japan 7th Kotakudo GINZA Building, 5-14-5, Ginza, Chuo, Tokyo 104-0061 | +81 (0)3 5148 7910 www.datamonitorconsulting.com

2. RESULTS IN PRACTICE: HOW WE’VE HELPED OTHERS
OUR EXPERTISE
Experience across the lifecycle
We bring you over ten years of pharma and biotech focussed consulting experience, from shaping ideal TPPs in the preclinical settings and
developing robust pre-launch analyses, right through to managing the final years of patent life. Our tailored approaches ensure you are armed with
the best analysis and valuation to inform your decisions.
Consensus and collaboration
Datamonitor Consulting’s approach and style is focused on ensuring that all major data points and assumptions are presented to key stakeholders
and pressure-tested at multiple points during a project.
Transparent and robust market models
Our models are robust and sophisticated, yet remain fully transparent and user-friendly.
IN-LICENSING CANDIDATES EVALUATION INTERNAL PIPELINE PRODUCT ASSESSMENT
The Issue The Issue
Our client, a Top Ten pharma company, needed Our client needed a current market assessment
robust independent assessments with fast of potential opportunities and threats to their
turnaround to support their BDL valuation of Phase III product. They also requested an
three in-licensing targets. associated valuation.
Our Approach Our Approach
Our consultants structured a rapid-initiation, We sourced and analyzed the best available
rapid-turnaround framework to analyze and data, designed and conducted research to
summarize multiple elements, including: gather insights from key market stakeholders:
payers, treating physicians, patients and
• Target population treatment algorithm opinion leaders.
• Competitive landscape unmet stakeholder
needs We developed a transparent and robust forecast
• Pricing market access drivers which leveraged the insights from this process.
• Response to the Target Product Profile,
including share allocations risk-adjusted
patient-based forecasts
The Result The Result
Our assessment was completed in five weeks Our output identified high probability/high
and the results informed their final BDL impact events. We then estimated the product’s
decisions regarding the targets. potential and associated NPVs based on
different scenarios.
The success of the project led to an on-going
partnership: Datamonitor supports external Based upon this output, we offered actionable
assessments where the client is resource recommendations to support future investment
constrained or is dealing with unfamiliar and development planning.
therapy areas.
Our consultants operate globally; our head offices are located in:
UK 119 Farringdon Road, London EC1R 3DA | +44 (0)20 7675 7000
US 52 Vanderbilt Avenue, 7th Floor, New York, NY 10017 | +1 (212) 686 7400 info@datamonitorconsulting.com
Japan 7th Kotakudo GINZA Building, 5-14-5, Ginza, Chuo, Tokyo 104-0061 | +81 (0)3 5148 7910 www.datamonitorconsulting.com